These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21487811)

  • 1. MKK4 acts as a potential tumor suppressor in ovarian cancer.
    Yeasmin S; Nakayama K; Rahman MT; Rahman M; Ishikawa M; Katagiri A; Iida K; Nakayama N; Miyazaki K
    Tumour Biol; 2011 Aug; 32(4):661-70. PubMed ID: 21487811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of MKK4 expression in ovarian cancer: a potential role for the epithelial to mesenchymal transition.
    Yeasmin S; Nakayama K; Rahman MT; Rahman M; Ishikawa M; Katagiri A; Iida K; Nakayama N; Miyazaki K
    Int J Cancer; 2011 Jan; 128(1):94-104. PubMed ID: 20309881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional and clinicopathological analysis of loss of MKK4 expression in endometrial cancer.
    Ishikawa M; Nakayama K; Rahman MT; Rahman M; Katagiri A; Iida K; Miyazaki K
    Oncology; 2010; 79(3-4):238-46. PubMed ID: 21372598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the metastasis suppressor gene MKK4 in ovarian cancer.
    Spillman MA; Lacy J; Murphy SK; Whitaker RS; Grace L; Teaberry V; Marks JR; Berchuck A
    Gynecol Oncol; 2007 May; 105(2):312-20. PubMed ID: 17276500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitogen-activated protein kinase kinase 4 (MKK4) acts as a metastasis suppressor gene in human ovarian carcinoma.
    Yamada SD; Hickson JA; Hrobowski Y; Vander Griend DJ; Benson D; Montag A; Karrison T; Huo D; Rutgers J; Adams S; Rinker-Schaeffer CW
    Cancer Res; 2002 Nov; 62(22):6717-23. PubMed ID: 12438272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-Jun NH2-terminal kinase activating kinase 1/mitogen-activated protein kinase kinase 4-mediated inhibition of SKOV3ip.1 ovarian cancer metastasis involves growth arrest and p21 up-regulation.
    Lotan T; Hickson J; Souris J; Huo D; Taylor J; Li T; Otto K; Yamada SD; Macleod K; Rinker-Schaeffer CW
    Cancer Res; 2008 Apr; 68(7):2166-75. PubMed ID: 18381422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma.
    Hickson JA; Huo D; Vander Griend DJ; Lin A; Rinker-Schaeffer CW; Yamada SD
    Cancer Res; 2006 Feb; 66(4):2264-70. PubMed ID: 16489030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].
    Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted deletion of MKK4 in cancer cells: a detrimental phenotype manifests as decreased experimental metastasis and suggests a counterweight to the evolution of tumor-suppressor loss.
    Cunningham SC; Gallmeier E; Hucl T; Dezentje DA; Calhoun ES; Falco G; Abdelmohsen K; Gorospe M; Kern SE
    Cancer Res; 2006 Jun; 66(11):5560-4. PubMed ID: 16740690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of HSulf-1 expression by variant hepatic nuclear factor 1 in ovarian cancer.
    Liu P; Khurana A; Rattan R; He X; Kalloger S; Dowdy S; Gilks B; Shridhar V
    Cancer Res; 2009 Jun; 69(11):4843-50. PubMed ID: 19487294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time-dependent transcriptional profiling links gene expression to mitogen-activated protein kinase kinase 4 (MKK4)-mediated suppression of omental metastatic colonization.
    Bainer RO; Veneris JT; Yamada SD; Montag A; Lingen MW; Gilad Y; Rinker-Schaeffer CW
    Clin Exp Metastasis; 2012 Jun; 29(5):397-408. PubMed ID: 22350525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of semaphorin4D gene silencing on malignant behavior of human ovarian cancer SKOV3 cells].
    Chen Y; Zhang L; Wu HJ; Liu WX; Hao Q
    Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):324-30. PubMed ID: 21875458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of MKK4 pro-oncogenic activity in breast and pancreatic tumors.
    Wang L; Pan Y; Dai JL
    Oncogene; 2004 Aug; 23(35):5978-85. PubMed ID: 15184866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitogen-activated protein kinase kinase 4/c-Jun NH2-terminal kinase kinase 1 protein expression is subject to translational regulation in prostate cancer cell lines.
    Robinson VL; Shalhav O; Otto K; Kawai T; Gorospe M; Rinker-Schaeffer CW
    Mol Cancer Res; 2008 Mar; 6(3):501-8. PubMed ID: 18337456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian carcinomas: CCN genes are aberrantly expressed and CCN1 promotes proliferation of these cells.
    Gery S; Xie D; Yin D; Gabra H; Miller C; Wang H; Scott D; Yi WS; Popoviciu ML; Said JW; Koeffler HP
    Clin Cancer Res; 2005 Oct; 11(20):7243-54. PubMed ID: 16243794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological role and prognostic significance of NAC1 in ovarian cancer.
    Nakayama K; Rahman MT; Rahman M; Yeasmin S; Ishikawa M; Katagiri A; Iida K; Nakayama N; Miyazaki K
    Gynecol Oncol; 2010 Dec; 119(3):469-78. PubMed ID: 20869761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decitabine and suberoylanilide hydroxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor suppressor genes, apoptosis, G2/M arrest, and autophagy.
    Chen MY; Liao WS; Lu Z; Bornmann WG; Hennessey V; Washington MN; Rosner GL; Yu Y; Ahmed AA; Bast RC
    Cancer; 2011 Oct; 117(19):4424-38. PubMed ID: 21491416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced Klotho expression contributes to poor survival rates in human patients with ovarian cancer, and overexpression of Klotho inhibits the progression of ovarian cancer partly via the inhibition of systemic inflammation in nude mice.
    Yan Y; Wang Y; Xiong Y; Lin X; Zhou P; Chen Z
    Mol Med Rep; 2017 Apr; 15(4):1777-1785. PubMed ID: 28259911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.
    Xia B; Yang S; Liu T; Lou G
    Mol Cancer; 2015 Mar; 14():57. PubMed ID: 25889927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and mutation analyses of MKK4, a candidate tumour suppressor gene encoded by chromosome 17p, in human gastric adenocarcinoma.
    Chae KS; Ryu BK; Lee MG; Byun DS; Chi SG
    Eur J Cancer; 2002 Oct; 38(15):2048-57. PubMed ID: 12376211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.